NEO - Company ID 0001077183
NEOGENOMICS INC (NEO) reported net income of -$108.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$108.00M | -36.7% |
| FY 2024 | -$79.00M | +10.2% |
| FY 2023 | -$88.00M | +38.9% |
| FY 2022 | -$144.00M | -1700.0% |
| FY 2021 | -$8.00M | -291.8% |
| FY 2020 | $4.17M | -47.9% |
| FY 2019 | $8.01M | +203.3% |
| FY 2018 | $2.64M | +766.7% |
| FY 2017 |
NEOGENOMICS INC (NEO) reported net income of -$108.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, NEOGENOMICS INC's net income declined from -$1.18M to -$108.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$396.00K |
| +93.6% |
| FY 2016 | -$6.14M | -142.3% |
| FY 2015 | -$2.54M | -323.9% |
| FY 2014 | $1.13M | -44.3% |
| FY 2013 | $2.03M | +3027.7% |
| FY 2012 | $65.00K | +105.5% |
| FY 2011 | -$1.18M | - |